Chiara Zecca
Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results.
Gantenbein A, Bonvin C, Kamm C, Schankin C, Zecca C, Zieglgänsberger D, Merki-Feld G, Pohl H, Rudolph N, Ryvlin P, Agosti R, Schäfer E, Meyer I, Kulartz-Schank M, Arzt M. Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results. J Neurol 2024
Jun 13, 2024Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results.
Jun 13, 2024J Neurol 2024
Gantenbein Andreas R, Bonvin Christophe, Kamm Christian Philipp, Schankin Christoph J, Zecca Chiara, Zieglgänsberger Dominik, Merki-Feld Gabriele Susanne, Pohl Heiko, Rudolph Nicole, Ryvlin Philippe, Agosti Reto, Schäfer Elisabeth, Meyer Ina, Kulartz-Schank Monika, Arzt Michael E
Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
Cagol A, Benkert P, Melie-Garcia L, Schaedelin S, Leber S, Tsagkas C, Barakovic M, Galbusera R, Lu P, Weigel M, Ruberte E, Radue E, Yaldizli O, Oechtering J, Lorscheider J, D'Souza M, Fischer-Barnicol B, Müller S, Achtnichts L, Vehoff J, Giulio D, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb J, Remonda L, Wagner F, Vargas M, Du Pasquier R, Lalive P, Pravatà E, Weber J, Cattin P, Absinta M, Gobbi C, Leppert D, Kappos L, Kuhle J, Granziera C. Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS. Neurology 2023; 102:e207768.
Dec 13, 2023Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
Dec 13, 2023Neurology 2023; 102:e207768
Cagol Alessandro, Benkert Pascal, Melie-Garcia Lester, Schaedelin Sabine A, Leber Selina, Tsagkas Charidimos, Barakovic Muhamed, Galbusera Riccardo, Lu Po-Jui, Weigel Matthias, Ruberte Esther, Radue Ernst-Wilhelm, Yaldizli Ozgür, Oechtering Johanna, Lorscheider Johannes, D'Souza Marcus, Fischer-Barnicol Bettina, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Giulio Disanto, Findling Oliver, Chan Andrew T, Salmen Anke, Pot Caroline, Bridel Claire, Zecca Chiara, Derfuss Tobias, Lieb Johanna Maria, Remonda Luca, Wagner Franca, Vargas Maria Isabel, Du Pasquier Renaud A, Lalive Patrice H, Pravatà Emanuele, Weber Johannes, Cattin Philippe C, Absinta Martina, Gobbi Claudio, Leppert David, Kappos Ludwig, Kuhle Jens, Granziera Cristina
Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis.
Abdelhak A, Benkert P, Schaedelin S, Boscardin W, Cordano C, Oechtering J, Ananth K, Granziera C, Melie-Garcia L, Montes S, Beaudry-Richard A, Achtnichts L, Oertel F, Lalive P, Leppert D, Müller S, Henry R, Pot C, Matthias A, Salmen A, Oksenberg J, Giulio D, Zecca C, D'Souza M, Du Pasquier R, Bridel C, Gobbi C, Kappos L, Hauser S, Cree B, Kuhle J, Green A, UCSF, MS EPIC, and the SMSC Study Teams. Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis. JAMA Neurol 2023
Nov 6, 2023Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis.
Nov 6, 2023JAMA Neurol 2023
Abdelhak Ahmed, Benkert Pascal, Schaedelin Sabine A, Boscardin W John, Cordano Christian, Oechtering Johanna, Ananth Kirtana, Granziera Cristina, Melie-Garcia Lester, Montes Shivany Condor, Beaudry-Richard Alexandra, Achtnichts Lutz, Oertel Frederike C, Lalive Patrice H, Leppert David, Müller Stefanie, Henry Roland G, Pot Caroline, Matthias Amandine, Salmen Anke, Oksenberg Jorge R, Giulio Disanto, Zecca Chiara, D'Souza Marcus, Du Pasquier Renaud A, Bridel Claire, Gobbi Claudio, Kappos Ludwig, Hauser Stephen L, Cree Bruce A C, Kuhle Jens, Green Ari J, UCSF, MS EPIC, and the SMSC Study Teams
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
Meier S, Willemse E, Schaedelin S, Oechtering J, Lorscheider J, Melie-Garcia L, Cagol A, Barakovic M, Galbusera R, Subramaniam S, Barro C, Abdelhak A, Thebault S, Achtnichts L, Lalive P, Müller S, Pot C, Salmen A, Giulio D, Zecca C, D'Souza M, Orleth A, Khalil M, Buchmann A, Du Pasquier R, Yaldizli O, Derfuss T, Berger K, Hermesdorf M, Wiendl H, Piehl F, Battaglini M, Fischer U, Kappos L, Gobbi C, Granziera C, Bridel C, Leppert D, Maceski A, Benkert P, Kuhle J. Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis. JAMA Neurol 2023; 80:287-297.
Mar 1, 2023Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
Mar 1, 2023JAMA Neurol 2023; 80:287-297
Meier Stephanie, Willemse Eline A J, Schaedelin Sabine A, Oechtering Johanna, Lorscheider Johannes, Melie-Garcia Lester, Cagol Alessandro, Barakovic Muhamed, Galbusera Riccardo, Subramaniam Suvitha, Barro Christian, Abdelhak Ahmed, Thebault Simon, Achtnichts Lutz, Lalive Patrice H, Müller Stefanie, Pot Caroline, Salmen Anke, Giulio Disanto, Zecca Chiara, D'Souza Marcus, Orleth Annette, Khalil Michael, Buchmann Arabella, Du Pasquier Renaud A, Yaldizli Ozgür, Derfuss Tobias, Berger Klaus, Hermesdorf Marco, Wiendl Heinz, Piehl Fredrik, Battaglini Marco, Fischer Urs, Kappos Ludwig, Gobbi Claudio, Granziera Cristina, Bridel Claire, Leppert David, Maceski Aleksandra Maleska, Benkert Pascal, Kuhle Jens
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.
Todea A, Melie-Garcia L, Barakovic M, Cagol A, Rahmanzadeh R, Galbusera R, Lu P, Weigel M, Ruberte E, Radue E, Schaedelin S, Benkert P, Oezguer Y, Sinnecker T, Müller S, Achtnichts L, Vehoff J, Disanto G, Findling O, Chan A, Salmen A, Pot C, Lalive P, Bridel C, Zecca C, Derfuss T, Remonda L, Wagner F, Vargas M, Du Pasquier R, Pravatà E, Weber J, Gobbi C, Leppert D, Wuerfel J, Kober T, Marechal B, Corredor-Jerez R, Psychogios M, Lieb J, Kappos L, Cuadra M, Kuhle J, Granziera C. A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients. J Magn Reson Imaging 2023
Jan 28, 2023A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.
Jan 28, 2023J Magn Reson Imaging 2023
Todea Alexandra Ramona, Melie-Garcia Lester, Barakovic Muhamed, Cagol Alessandro, Rahmanzadeh Reza, Galbusera Riccardo, Lu Po-Jui, Weigel Matthias, Ruberte Esther, Radue Ernst-Wilhelm, Schaedelin Sabine, Benkert Pascal, Oezguer Yaldizli, Sinnecker Tim, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Disanto Giulio, Findling Oliver, Chan Andrew, Salmen Anke, Pot Caroline, Lalive Patrice, Bridel Claire, Zecca Chiara, Derfuss Tobias, Remonda Luca, Wagner Franca, Vargas Maria I, Du Pasquier Renaud, Pravatà Emanuele, Weber Johannes, Gobbi Claudio, Leppert David, Wuerfel Jens, Kober Tobias, Marechal Benedicte, Corredor-Jerez Ricardo, Psychogios Marios, Lieb Johanna, Kappos Ludwig, Cuadra Meritxell Bach, Kuhle Jens, Granziera Cristina
Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS).
Achtnichts L, Zecca C, Findling O, Kamm C, Müller S, Kuhle J, Lutterotti A, Gobbi C, Viviani C, Villiger-Borter E, Nedeltchev K. Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS). BMJ Neurol Open 2023; 5:e000304.
Jan 26, 2023Correlation of disability with quality of life in patients with multiple sclerosis treated with natalizumab: primary results and post hoc analysis of the TYSabri ImPROvement study (PROTYS).
Jan 26, 2023BMJ Neurol Open 2023; 5:e000304
Achtnichts Lutz, Zecca Chiara, Findling Oliver, Kamm Christian Philipp, Müller Stefanie, Kuhle Jens, Lutterotti Andreas, Gobbi Claudio, Viviani Camille, Villiger-Borter Emanuela, Nedeltchev Krassen
Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022
Friedli C, Salmen A, Achtnichts L, Derfuss T, Gobbi C, Kuhle J, Lalive P, Müller S, Papadopoulou A, Pot C, Zecca C, Chan A, Kamm C. Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022. Clinical and Translational Neuroscience 2022
Dec 22, 2022Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022
Dec 22, 2022Clinical and Translational Neuroscience 2022
Friedli Christoph, Salmen Anke, Achtnichts Lutz, Derfuss Tobias, Gobbi Claudio, Kuhle Jens, Lalive Patrice, Müller Stefanie, Papadopoulou Athina, Pot Caroline, Zecca Chiara, Chan Andrew, Kamm Christian P.
Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis.
Cagol A, Schaedelin S, Barakovic M, Benkert P, Todea R, Rahmanzadeh R, Galbusera R, Lu P, Weigel M, Melie-Garcia L, Ruberte E, Siebenborn N, Battaglini M, Radue E, Yaldizli O, Oechtering J, Sinnecker T, Lorscheider J, Fischer-Barnicol B, Müller S, Achtnichts L, Vehoff J, Giulio D, Findling O, Chan A, Salmen A, Pot C, Bridel C, Zecca C, Derfuss T, Lieb J, Remonda L, Wagner F, Vargas M, Du Pasquier R, Lalive P, Pravatà E, Weber J, Cattin P, Gobbi C, Leppert D, Kappos L, Kuhle J, Granziera C. Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis. JAMA Neurol 2022; 79:682-692.
Jul 1, 2022Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis.
Jul 1, 2022JAMA Neurol 2022; 79:682-692
Cagol Alessandro, Schaedelin Sabine A, Barakovic Muhamed, Benkert Pascal, Todea Ramona-Alexandra, Rahmanzadeh Reza, Galbusera Riccardo, Lu Po-Jui, Weigel Matthias, Melie-Garcia Lester, Ruberte Esther, Siebenborn Nina, Battaglini Marco, Radue Ernst-Wilhelm, Yaldizli Ozgür, Oechtering Johanna, Sinnecker Tim, Lorscheider Johannes, Fischer-Barnicol Bettina, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Giulio Disanto, Findling Oliver, Chan Andrew T, Salmen Anke, Pot Caroline, Bridel Claire, Zecca Chiara, Derfuss Tobias, Lieb Johanna Maria, Remonda Luca, Wagner Franca, Vargas Maria I, Du Pasquier Renaud A, Lalive Patrice H, Pravatà Emanuele, Weber Johannes, Cattin Philippe C, Gobbi Claudio, Leppert David, Kappos Ludwig, Kuhle Jens, Granziera Cristina
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
Oechtering J, Naegelin Y, Maceski A, Meier S, Berger K, Wiendl H, Lincke T, Lieb J, Yaldizli O, Sinnecker T, Derfuss T, Regeniter A, Zecca C, Gobbi C, Kappos L, Granziera C, Leppert D, Kuhle J, Conen D, Aeschbacher S, Subramaniam S, Schaedelin S, Benkert P, Müller S, Achtnichts L, Vehoff J, Giulio D, Findling O, Fischer-Barnicol B, Orleth A, Chan A, Pot C, Barakovic M, Rahmanzadeh R, Galbusera R, Heijnen I, Lalive P, Wuerfel J, Swiss Multiple Sclerosis Cohort Study. Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis. Ann Neurol 2021; 90:477-489.
Jun 22, 2021Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
Jun 22, 2021Ann Neurol 2021; 90:477-489
Oechtering Johanna, Naegelin Yvonne, Maceski Aleksandra, Meier Stephanie, Berger Klaus, Wiendl Heinz, Lincke Therese, Lieb Johanna, Yaldizli Ozgür, Sinnecker Tim, Derfuss Tobias, Regeniter Axel, Zecca Chiara, Gobbi Claudio, Kappos Ludwig, Granziera Cristina, Leppert David, Kuhle Jens, Conen David, Aeschbacher Stefanie, Subramaniam Suvitha, Schaedelin Sabine, Benkert Pascal, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Giulio Disanto, Findling Oliver, Fischer-Barnicol Bettina, Orleth Annette, Chan Andrew, Pot Caroline, Barakovic Muhamed, Rahmanzadeh Reza, Galbusera Riccardo, Heijnen Ingmar, Lalive Patrice H, Wuerfel Jens, Swiss Multiple Sclerosis Cohort Study
Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study
Gantenbein A, Agosti R, Gobbi C, Flügel D, Schankin C, Viceic D, Zecca C, Pohl H. Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study. Cephalalgia 2021; 41:1181-1186.
May 17, 2021Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study
May 17, 2021Cephalalgia 2021; 41:1181-1186
Gantenbein Andreas R, Agosti Reto, Gobbi Claudio, Flügel Dominique, Schankin Christoph J, Viceic Dragana, Zecca Chiara, Pohl Heiko
Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?
Rodgers S, Calabrese P, Ajdacic-Gross V, Steinemann N, Kaufmann M, Salmen A, Manjaly Z, Kesselring J, Kamm C, Kuhle J, Chan A, Gobbi C, Zecca C, Müller S, von Wyl V. Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?. J Psychosom Res 2021; 144:110402.
Feb 16, 2021Major depressive disorder subtypes and depression symptoms in multiple sclerosis: What is different compared to the general population?
Feb 16, 2021J Psychosom Res 2021; 144:110402
Rodgers Stephanie, Calabrese Pasquale, Ajdacic-Gross Vladeta, Steinemann Nina, Kaufmann Marco, Salmen Anke, Manjaly Zina-Mary, Kesselring Jürg, Kamm Christian Philipp, Kuhle Jens, Chan Andrew T, Gobbi Claudio, Zecca Chiara, Müller Stefanie, von Wyl Viktor
Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary.
Achtnichts L, Salmen A, Chan A, Czaplinski A, Derfuss T, Du Pasquier R, Findling O, Gobbi C, Zecca C, Müller S, Kamm C, Kuhle J, Lalive P, Martin R, Pot C, Papadopoulou A. Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary. Clinical and Translational Neuroscience 2019
Mar 1, 2019Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary.
Mar 1, 2019Clinical and Translational Neuroscience 2019
Achtnichts Lutz, Salmen Anke, Chan Andrew, Czaplinski Adam, Derfuss Tobias, Du Pasquier R, Findling Oliver, Gobbi Claudio, Zecca Chiara, Müller Stefanie, Kamm CP, Kuhle Jens, Lalive Patrice H, Martin Roland, Pot Caroline, Papadopoulou Athina
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
Disanto G, Barro C, Benkert P, Naegelin Y, Schädelin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J, Swiss Multiple Sclerosis Cohort Study Group. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis. Ann Neurol 2017; 81:857-870.
Jun 1, 2017Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
Jun 1, 2017Ann Neurol 2017; 81:857-870
Disanto Giulio, Barro Christian, Benkert Pascal, Naegelin Yvonne, Schädelin Sabine, Giardiello Antonella, Zecca Chiara, Blennow Kaj, Zetterberg Henrik, Leppert David, Kappos Ludwig, Gobbi Claudio, Kuhle Jens, Swiss Multiple Sclerosis Cohort Study Group
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
Zhang K, Arcuti S, Brunetti M, Moglia C, Calvo A, Ratti A, Tiloca C, Gellera C, Pensato V, Mazzini L, Capozzo R, Zecca C, Blair I, Stuit R, Muller B, Filosto M, Padovani A, Riva N, Penco S, Lunetta C, Sorarù G, Bertolin C, Blauw H, Curtis C, Hofman A, Estrada K, Rivadeneira F, Uitterlinden A, Dartigues J, Tzourio C, Amouyel P, van der Kooi A, de Visser M, D'Alfonso S, Comi G, Del Bo R, Cereda C, Pansarasa O, Smith B, Shaw C, Weber M, Goris A, Nöthen M, McCann E, Veldink J, Corcia P, Andersen P, Hardiman O, Landers J, Glass J, Brown R, Pers T, Franke L, Van Damme P, Vourc'h P, Silani V, van den Berg L, Al-Chalabi A, Breen G, Lewis C, Pasterkamp R, van Es M, de Bakker P, Visscher P, Wray N, Robberecht W, Weishaupt J, Stubendorff B, Prell T, Ringer T, Witte O, Grosskreutz J, Kiernan M, Pamphlett R, Rowe D, Nicholson G, Kurth I, Hübner C, Ludolph A, Powell J, Logroscino G, Tortelli R, Pupillo E, Beghi E, Chio A, Casale F, Leigh P, Fifita J, Chandran S, Koritnik B, Ravnik-Glavač M, Vrabec K, Rogelj B, Lin K, Ticozzi N, Vajda A, Menelaou A, Medic J, Zidar J, Leonardis L, Polak M, Rojas-García R, Mora J, Pinto S, de Carvalho M, Meininger V, Salachas F, Millecamps S, Grošelj L, Brands W, Schellevis R, Robinson M, de Jong S, Võsa U, van der Spek R, Pulit S, Diekstra F, McLaughlin R, Dekker A, Shatunov A, Yang J, Fogh I, Harschnitz O, van Eijk K, Kenna K, Jones A, Sproviero W, Blokhuis A, Koppers M, Tazelaar G, van Doormaal P, van Rheenen W, Colville S, Cichon S, Maurel C, Andres C, Radivojkov-Blagojevic M, Lichtner P, Meitinger T, Parman Y, Hamzeiy H, Tunca C, Basak A, Bensimon G, Landwehrmeyer B, Rietschel M, Franke A, Lieb W, Tittmann L, Wood N, Dürr A, Saker-Delye S, Payan C, Brice A, McCluskey L, Elman L, Topp S, Malaspina A, Fratta P, Sidle K, Pittman A, Orrell R, Hardy J, Shaw P, Morrison K, Petri S, Abdulla S, Trojanowski J, Van Deerlin V, Lomen-Hoerth C, Wiedau-Pazos M, Staats K, Ophoff R, Meyer T, Sendtner M, Drepper C, Swingler R. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet 2016; 48:1043-8.
Jul 25, 2016Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
Jul 25, 2016Nat Genet 2016; 48:1043-8
Zhang Katharine, Arcuti Simona, Brunetti Maura, Moglia Cristina, Calvo Andrea, Ratti Antonia, Tiloca Cinzia, Gellera Cinzia, Pensato Viviana, Mazzini Letizia, Capozzo Rosa, Zecca Chiara, Blair Ian, Stuit Robbert Jan, Muller Bernard, Filosto Massimiliano, Padovani Alessandro, Riva Nilo, Penco Silvana, Lunetta Christian, Sorarù Gianni, Bertolin Cinzia, Blauw Hylke M, Curtis Charles, Hofman Albert, Estrada Karol, Rivadeneira Fernando, Uitterlinden André G, Dartigues Jean-François, Tzourio Christophe, Amouyel Philippe, van der Kooi Anneke J, de Visser Marianne, D'Alfonso Sandra, Comi Giacomo P, Del Bo Roberto, Cereda Cristina, Pansarasa Orietta, Smith Bradley N, Shaw Christopher E, Weber Markus, Goris An, Nöthen Markus M, McCann Emily P, Veldink Jan H, Corcia Philippe, Andersen Peter M, Hardiman Orla, Landers John E, Glass Jonathan D, Brown Robert H, Pers Tune H, Franke Lude, Van Damme Philip, Vourc'h Patrick, Silani Vincenzo, van den Berg Leonard H, Al-Chalabi Ammar, Breen Gerome, Lewis Cathryn M, Pasterkamp R Jeroen, van Es Michael A, de Bakker Paul I W, Visscher Peter M, Wray Naomi R, Robberecht Wim, Weishaupt Jochen H, Stubendorff Beatrice, Prell Tino, Ringer Thomas, Witte Otto W, Grosskreutz Julian, Kiernan Matthew C, Pamphlett Roger, Rowe Dominic B, Nicholson Garth A, Kurth Ingo, Hübner Christian A, Ludolph Albert C, Powell John, Logroscino Giancarlo, Tortelli Rosanna, Pupillo Elisabetta, Beghi Ettore, Chio Adriano, Casale Federico, Leigh P Nigel, Fifita Jennifer A, Chandran Siddharthan, Koritnik Blaž, Ravnik-Glavač Metka, Vrabec Katarina, Rogelj Boris, Lin Kuang, Ticozzi Nicola, Vajda Alice, Menelaou Androniki, Medic Jelena, Zidar Janez, Leonardis Lea, Polak Meraida, Rojas-García Ricardo, Mora Jesus S, Pinto Susana, de Carvalho Mamede, Meininger Vincent, Salachas François, Millecamps Stéphanie, Grošelj Leja Dolenc, Brands William J, Schellevis Raymond D, Robinson Matthew R, de Jong Simone, Võsa Urmo, van der Spek Rick A A, Pulit Sara L, Diekstra Frank P, McLaughlin Russell L, Dekker Annelot M, Shatunov Aleksey, Yang Jian, Fogh Isabella, Harschnitz Oliver, van Eijk Kristel R, Kenna Kevin P, Jones Ashley R, Sproviero William, Blokhuis Anna M, Koppers Max, Tazelaar Gijs H P, van Doormaal Perry Tc, van Rheenen Wouter, Colville Shuna, Cichon Sven, Maurel Cindy, Andres Christian R, Radivojkov-Blagojevic Milena, Lichtner Peter, Meitinger Thomas, Parman Yesim, Hamzeiy Hamid, Tunca Ceren, Basak A Nazli, Bensimon Gilbert, Landwehrmeyer Bernhard, Rietschel Marcella, Franke Andre, Lieb Wolfgang, Tittmann Lukas, Wood Nicholas W, Dürr Alexandra, Saker-Delye Safaa, Payan Christine A M, Brice Alexis, McCluskey Leo, Elman Lauren, Topp Simon, Malaspina Andrea, Fratta Pietro, Sidle Katie, Pittman Alan, Orrell Richard W, Hardy John, Shaw Pamela J, Morrison Karen E, Petri Susanne, Abdulla Susanne, Trojanowski John Q, Van Deerlin Vivianna M, Lomen-Hoerth Catherine, Wiedau-Pazos Martina, Staats Kim A, Ophoff Roel A, Meyer Thomas, Sendtner Michael, Drepper Carsten, Swingler Robert
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
Giulio D, Kamm C, Mattle H, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive P, Yaldizli O, Gobbi C, Kappos L, Kuhle J, Louvion J, Derfuss T, Stippich C, Benkert P, Lorscheider J, Müller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue E, Sprenger T, SMSC Scientific Board. The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options. PloS one 2016; 11:e0152347.
Mar 31, 2016The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
Mar 31, 2016PloS one 2016; 11:e0152347
Giulio Disanto, Kamm Christian P, Mattle Heinrich P, Lotter Christoph, Du Pasquier Renaud, Schluep Myriam, Pot Caroline, Lalive Patrice H, Yaldizli Ozgür, Gobbi Claudio, Kappos Ludwig, Kuhle Jens, Louvion Jean-François, Derfuss Tobias, Stippich Christoph, Benkert Pascal, Lorscheider Johannes, Müller Stefanie, Vehoff Jochen, Zecca Chiara, Ramseier Simon, Achtnichts Lutz, Findling Oliver, Nedeltchev Krassen, Radue Ernst-Wilhelm, Sprenger Till, SMSC Scientific Board
Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies
Gobbi C, Zecca C, Linnebank M, Müller S, You X, Meier R, Borter E, Traber M. Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies. Eur Neurol 2013; 70:35-41.
May 14, 2013Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies
May 14, 2013Eur Neurol 2013; 70:35-41
Gobbi Claudio, Zecca Chiara, Linnebank Michael, Müller Stefanie, You Xiaojun, Meier Rosetta, Borter Emmanuela, Traber Martin